trial

Guideline vs Usual Treatment in Schizophrenic Adolescents

NCTId NCT02573701
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 91 (actual)
Sponsored by Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico
Primary completion 2015-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
91 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2011-10
Primary completion
2015-06
Eligibility
ALL · 12 Years · 17 Years

Interventions & indications

Drugs
Risperidone"Psychosocial treatment"

Sponsors

Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, MexicoLead Sponsor

Investigators

1
Rosa E. Ulloa, Md PhdPrincipal Investigator

Sites

0 total

Facts & assertions

4 sourced
Enrollment
91
Phase
NA
Primary Completion Date
2015-06
Status
COMPLETED
relationships
The graph out of here
drug
Risperidone
drug
"Psychosocial treatment"
drug
lead_sponsor
Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Rosa E. Ulloa, Md Phd
person